Top Health Tools
Top Health Tools

Top Reports
Top Reports
Top Articles
Top Articles

Top Reviews
Top Reviews
Reports on H1N1 By The CDC Are
Designed To Withhold Key Information

The failure of the CDC to report critical changes of the H1N1 virus and its effective transmission, indicates their weekly reports are carefully designed to withhold key information.

A recent spike in cases with antiviral resistance have been reported in the U.S. Of the 29 total cases identified, 19 patients had documented exposure to Tamiflu through either treatment or chemoprophylaxis. Of the cases identified, 16 of them have come in the past 4 weeks, which is much higher than previous weeks, which were typically sporadic.

This recent spike in cases has also been reported by WHO and raises concerns that an upgraded form of the H1N1 virus efficiently transmitting. Moreover, recent deaths of patients with the upgraded form in the US (four of ten) and the Netherlands (four of eleven) have raised concerns that these patients may also have inherited other changes to the virus which have been associated with fatal cases in the US, Ukraine, Norway, Brazil, and France.

However, the CDC report does address those concerns. They do not distinguish between these recent samples and those collected in the spring or summer. Similarly, the location of these cases or outcomes are not made public, and there is no differentiation between patients who developed resistance during treatment and patients who were resistant prior to treatment. They only classify "suspect" cases on the basis that they failed to respond to Tamiflu which conveniently leaves the issue interpretation by other experts and agencies.

The Vietnam cluster described in this week's New England Journal of Medicine would represent such cases. Seven passengers on a train developed H1N1 infections that had the resistant strain. However, like most patients worldwide, the resistance was not discovered until long after treatment and discharge. The infections were in July, but the first lab confirmations were in September. Although Tamiflu treatment is not effective against H1N1 with the resistant strains (H275Y/H274Y), all patients recovered, but clearly represented infections of a fit and readily transmissible version of H1N1.

However, using the CDC classification system, these patients would have "documented exposure to Tamiflu" but would not be examples of resistance that developed due to treatment.

Although this is the CDC's largest category, they have yet to show a single example of a case that developed resistance after treatment with Tamiflu.

The failure of the CDC to report critical information such as changes to the virus and resistance to treatment raise concerns that the weekly reports by the CDC are carefully designed to withhold key information, including status prior to treatment, the dates and locations of samples, as well as outcomes of patients who are positive for H1N1 resistant strains.

In early November, the CDC and World Health Organization (WHO) were strongly criticized for manipulatiing swine flu deaths by stating that 4,000 Americans - rather than about 1,200 - had died of swine flu since the disease emerged in April. That new estimate by the CDC combined deaths from laboratory-confirmed cases of the flu and deaths that appeared to be brought on by flu, even though the patients may have ultimately died of bacterial pneumonia, other infections or organ failure.

This intrinsic manipulation and lack of transparency by the CDC continues to be hazardous to the world's health.

Reference Source 133, 172, 242, 243
December 14, 2009

STAY CONNECTEDNewsletter | RSS | Twitter | YouTube |
This site is owned and operated by 1999-2018. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
volunteerDonateWrite For Us
Stay Connected With Our Newsletter